Lipid-binding and antimicrobial properties of synthetic peptides of bovine apolipoprotein A-II

Biochem J. 1999 Aug 15;342 ( Pt 1)(Pt 1):215-21.

Abstract

We previously showed that bovine apolipoprotein A-II (apoA-II) had antimicrobial activity against Escherichia coli and the yeast Saccharomyces cerevisiae in PBS. We have characterized here the active domain of apoA-II using synthetic peptides. A peptide corresponding to C-terminal residues Leu(49)-Thr(76) exhibited significant antimicrobial activity against E. coli in PBS, but not against S. cerevisiae. Experiments using amino-acid-substituted peptides indicated that the residues Phe(52)-Phe(53)-Lys(54)-Lys(55) are required for the activity. Peptide Leu(49)-Thr(76) induced the release of calcein trapped inside the vesicles whose lipid composition resembles that of E. coli membrane, suggesting that peptide Leu(49)-Thr(76) can destabilize the E. coli membrane. CD measurements showed that the alpha-helicity of peptide Leu(49)-Thr(76) increased from 3.5 to 36% by addition of the vesicles. When E. coli cells were incubated with peptide Leu(49)-Thr(76), some proteins were released to the external medium, probably owing to membrane destabilization caused by the peptide. In electron micrographs of E. coli cells treated with peptide Leu(49)-Thr(76), transparent nucleoids and granulated cytoplasm were observed. Amino acid substitutions, Phe(52)Phe(53)-->AlaAla (Phe(52, 53)-->Ala) in peptide Leu(49)-Thr(76) caused the loss of antimicrobial activity against E. coli, although protein-releasing activity was retained. Electron micrographs of the cells treated with peptide Leu(49)-Thr(76)(Phe(52,53)-->Ala) revealed morphological change only at the nucleoids. Therefore peptide Leu(49)-Thr(76) appears to primarily target the cytoplasm rather than the membrane of E. coli cells.

MeSH terms

  • Amino Acid Sequence
  • Amino Acid Substitution
  • Animals
  • Anti-Bacterial Agents
  • Anti-Infective Agents / chemistry
  • Anti-Infective Agents / isolation & purification
  • Anti-Infective Agents / metabolism
  • Anti-Infective Agents / pharmacology*
  • Apolipoprotein A-II / chemistry
  • Apolipoprotein A-II / isolation & purification
  • Apolipoprotein A-II / metabolism*
  • Apolipoprotein A-II / pharmacology*
  • Bacterial Proteins / chemistry
  • Bacterial Proteins / metabolism
  • Cattle
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Circular Dichroism
  • Cytoplasm / drug effects
  • Cytoplasm / metabolism
  • Escherichia coli / cytology
  • Escherichia coli / drug effects*
  • Escherichia coli / metabolism
  • Escherichia coli / ultrastructure
  • Fluoresceins / metabolism
  • Inhibitory Concentration 50
  • Microscopy, Electron
  • Molecular Sequence Data
  • Molecular Weight
  • Peptide Fragments / chemical synthesis
  • Peptide Fragments / chemistry
  • Peptide Fragments / metabolism*
  • Peptide Fragments / pharmacology
  • Phospholipids / metabolism*
  • Protein Binding
  • Protein Structure, Secondary
  • Saccharomyces cerevisiae / cytology
  • Saccharomyces cerevisiae / drug effects
  • Sodium Chloride / pharmacology

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Apolipoprotein A-II
  • Bacterial Proteins
  • Fluoresceins
  • Peptide Fragments
  • Phospholipids
  • Sodium Chloride
  • fluorexon